Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer

Seminars in Urologic Oncology

Volumn 20, Issue 1, 2002, Pages 10-17

  Wilt, Timothy J ^a  

^a Minneapolis VA Center for Chronic Disease Outcomes Research   (United States)

Author keywords

Early detection; Expectant management; Prostate cancer; Randomized controlled trials; Shared decision making; Treatment

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CRYOTHERAPY; EARLY DIAGNOSIS; HUMAN; LABORATORY DIAGNOSIS; LIFE EXPECTANCY; MALE; MEDICAL DECISION MAKING; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0036170946     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.30393     Document Type: Review

References (23)

1. A comparison of treatment recommendations for men with clinically localized prostate cancer by urologists and radiation oncologists
2. Prostate cancer: Numbers may not tell the whole story
3. Prostate cancer: Different incidence but not mortality trends within two areas of Tuscany, Italy
4. Prostate cancer trends in three counties in Sweden 1987-1996: Results from a population-based register
5. Radical surgery versus radiotherapy for adenocarcinoma of the prostate
6. Prostate carcinoma incidence and patient mortality. The effects of screening and early detection
7. Prostate cancer: To screen or not to screen?
8. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study
9. Hormone replacement therapy and heart disease prevention. Experimentation trumps observation
10. Screening for prostate cancer
11. Can a clinical trial be the treatment of choice for patients with cancer?
12. The Prostate cancer Intervention Versus Observation Trial (PIVOT)
13. Informed decision making in outpatient practice. Time to get back to basics
14. Identifying systematic reviews: Key resources
15. The benefits of, controversies surrounding, and professional recommendations for routine PSA testing: What do men believe?
16. Decision aids for patients facing health treatment or screening decisions: Systematic review
17. Assessment of the feasibility and impact of shared decision making in prostate cancer
18. The importance of patient preference in the decision to screen for prostate cancer
19. What should men know about prostate-specific antigen screening before giving informed consent?
20. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet
21. Prostate-specific-antigen testing for early diagnosis of prostate cancer